Company Unveils Groundbreaking Approach to Pre- and Post-Procedure Skincare NEWPORT BEACH, Calif., April 5, 2023 /PRNewswire/ — ELEVAI LABS, INC., a science-based, data-driven aesthetic skincare firm, will launch its revolutionary core expertise platform, PREx™ (Precision Regenerative Exosome Technology™) from The American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Phoenix on April thirteenth.
Co-Founded by Dr. Jordan Plews, a Stanford-trained scientist with a background in biochemical engineering and stem cell analysis, ELEVAI’s trailblazing aesthetics functions are revolutionizing pre- and post-procedure skincare. PREx™, ELEVAI’s proprietary expertise platform, harnesses the ability of exosomes — nanoparticle compartments filled with development components, to optimize the looks of pores and skin and enhance the affected person expertise. All ELEVAI science-backed formulations characteristic ELEVAI Exosomes™ as the first ingredient that mimics the elegant organic components of nature concerned in restore and restoration, which helps the pores and skin’s pure therapeutic course of.
During ASLMS, ELEVAI will lead the dialog round topical exosomes and their transformative method to pre- and post-procedural skincare. Dr. Jordan Plews and Dr. Natalie Curcio will unveil PREx™ and its skill to remodel the skincare business whereas presenting new information quantifying the looks of the discount of redness and pigmentation in topics’ pores and skin at week eight and week twelve of every day topical utility of ELEVAI merchandise, obtained by the Canfield Reveal Imaging System.
The ELEVAI E-Series™ is the first-to-market topical exosome product sequence deliberately developed to help pores and skin earlier than and after energy-based procedures to optimize aesthetic outcomes and elevate the affected person expertise.”This method to skincare will revolutionize the best way sufferers care for his or her pores and skin main as much as and following in-office procedures,” added Dr. Natalie Curcio. “The ASLMS Meeting supplies the proper platform for ELEVAI to showcase its groundbreaking expertise. We stay up for sharing a deeper understanding of the capability for utilizing exosomes pre-and post-treatment.”Behind the whole lot we do is the need to supply revolutionary, secure, high-quality, and efficacious formulations.” shared Dr. Jordan Plews. “We are excited to unveil PREx™ on the ASLMS Meeting and share our transformative method to topical exosome skincare. New information suggests ELEVAI’s proprietary PREx Technology™ helps aesthetic suppliers ship improved outcomes for sufferers, contributing in the direction of lowered restoration time and improved outcomes.”ABOUT ELEVAI LABS, INC.ELEVAI LABS, INC. is a medical aesthetic biotechnology firm growing cutting-edge physician-dispensed skincare functions. The firm solves the unmet wants within the aesthetic skincare area by a mix of cutting-edge science and next-generation client functions. ELEVAI Labs develops state-of-the-art topical aesthetic skincare, with a give attention to leveraging a proprietary stem cell exosome expertise. Learn extra about ELEVAI Skincare at www.elevaiskincare.com.Media ContactBrenda BuechlerChief Marketing Officer [email protected]Investor ContactTyler Troup [email protected]SOURCE Elevai Labs Inc.